NASDAQ:RKDA - Arcadia Biosciences Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$10.27 +0.47 (+4.80 %)
(As of 05/22/2018 03:16 AM ET)
Previous Close$9.80
Today's Range$9.79 - $10.58
52-Week Range$3.60 - $66.56
Volume385,455 shs
Average Volume576,297 shs
Market Capitalization$24.32 million
P/E Ratio-1.50
Dividend YieldN/A
Beta-5.7

About Arcadia Biosciences (NASDAQ:RKDA)

Arcadia Biosciences logoArcadia Biosciences, Inc., an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits. It also provides nutritional oils comprising gamma linolenic acid safflower oil to manufacturers of dietary and nutritional supplements, medical foods, dog food, and other products under the SONOVA brand; and arachidonic acid safflower oil that is used as an ingredient in infant nutrition products. In addition, the company has various programs under development comprising fiber resistant starch wheat, whole grain flour, and reduced gluten wheat programs. Arcadia Biosciences, Inc. has strategic collaboration with Dow AgroSciences to develop and commercialize enhanced wheat quality trait. The company was founded in 2002 and is headquartered in Davis, California.

Receive RKDA News and Ratings via Email

Sign-up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNASDAQ:RKDA
CUSIPN/A
Phone530-756-7077

Debt

Debt-to-Equity RatioN/A
Current Ratio7.01
Quick Ratio6.91

Price-To-Earnings

Trailing P/E Ratio-1.50
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$4.03 million
Price / Sales6.32
Cash FlowN/A
Price / CashN/A
Book Value$3.75 per share
Price / Book2.74

Profitability

EPS (Most Recent Fiscal Year)($6.86)
Net Income$-15,700,000.00
Net Margins-686.10%
Return on Equity-259.46%
Return on Assets-82.98%

Miscellaneous

Employees42
Outstanding Shares2,480,000

Arcadia Biosciences (NASDAQ:RKDA) Frequently Asked Questions

What is Arcadia Biosciences' stock symbol?

Arcadia Biosciences trades on the NASDAQ under the ticker symbol "RKDA."

When did Arcadia Biosciences' stock split? How did Arcadia Biosciences' stock split work?

Shares of Arcadia Biosciences reverse split on Wednesday, January 24th 2018. The 1-20 reverse split was announced on Tuesday, January 23rd 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 23rd 2018. An investor that had 100 shares of Arcadia Biosciences stock prior to the reverse split would have 5 shares after the split.

How were Arcadia Biosciences' earnings last quarter?

Arcadia Biosciences (NASDAQ:RKDA) released its earnings results on Wednesday, May, 9th. The basic materials company reported ($4.86) EPS for the quarter. The basic materials company had revenue of $0.21 million for the quarter. Arcadia Biosciences had a negative return on equity of 259.46% and a negative net margin of 686.10%. View Arcadia Biosciences' Earnings History.

When is Arcadia Biosciences' next earnings date?

Arcadia Biosciences is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for Arcadia Biosciences.

What price target have analysts set for RKDA?

1 brokerages have issued 1-year price targets for Arcadia Biosciences' stock. Their forecasts range from $20.00 to $20.00. On average, they anticipate Arcadia Biosciences' stock price to reach $20.00 in the next twelve months. View Analyst Ratings for Arcadia Biosciences.

Who are some of Arcadia Biosciences' key competitors?

Who are Arcadia Biosciences' key executives?

Arcadia Biosciences' management team includes the folowing people:
  • Mr. Rajendra Ketkar, Pres, CEO & Director (Age 64)
  • Mr. Matthew T. Plavan, CFO & Sec. (Age 54)
  • Dr. Zhongjin Lu Ph.D., VP of Product Devel. (Age 52)
  • Ms. Sarah Reiter, Chief Commercial Officer (Age 46)

When did Arcadia Biosciences IPO?

(RKDA) raised $66 million in an initial public offering on Friday, May 15th 2015. The company issued 8,200,000 shares at a price of $8.00 per share. Credit Suisse, J.P. Morgan and Piper Jaffray acted as the underwriters for the IPO.

Has Arcadia Biosciences been receiving favorable news coverage?

News coverage about RKDA stock has been trending somewhat positive on Tuesday, Accern Sentiment reports. The research firm ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Arcadia Biosciences earned a media sentiment score of 0.02 on Accern's scale. They also assigned media coverage about the basic materials company an impact score of 46.52 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are Arcadia Biosciences' major shareholders?

Arcadia Biosciences' stock is owned by a number of of retail and institutional investors. Top institutional investors include MORAL COMPASS CORP (52.80%) and Sabby Management LLC (6.06%). Company insiders that own Arcadia Biosciences stock include Eric J Rey, Roger Salameh, Steven F Brandwein and Zhongjin Lu. View Institutional Ownership Trends for Arcadia Biosciences.

Which major investors are buying Arcadia Biosciences stock?

RKDA stock was purchased by a variety of institutional investors in the last quarter, including Sabby Management LLC. View Insider Buying and Selling for Arcadia Biosciences.

How do I buy shares of Arcadia Biosciences?

Shares of RKDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Arcadia Biosciences' stock price today?

One share of RKDA stock can currently be purchased for approximately $10.27.

How big of a company is Arcadia Biosciences?

Arcadia Biosciences has a market capitalization of $24.32 million and generates $4.03 million in revenue each year. The basic materials company earns $-15,700,000.00 in net income (profit) each year or ($6.86) on an earnings per share basis. Arcadia Biosciences employs 42 workers across the globe.

How can I contact Arcadia Biosciences?

Arcadia Biosciences' mailing address is 202 COUSTEAU PLACE SUITE 105, DAVIS CA, 85018. The basic materials company can be reached via phone at 530-756-7077 or via email at [email protected]


MarketBeat Community Rating for Arcadia Biosciences (RKDA)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  64 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  125
MarketBeat's community ratings are surveys of what our community members think about Arcadia Biosciences and other stocks. Vote "Outperform" if you believe RKDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RKDA will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Arcadia Biosciences (NASDAQ:RKDA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Arcadia Biosciences in the last 12 months. Their average twelve-month price target is $20.00, suggesting that the stock has a possible upside of 94.74%. The high price target for RKDA is $20.00 and the low price target for RKDA is $20.00. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $20.00$20.00$20.00$20.00
Price Target Upside: 94.74% upside58.32% downside96.08% upside96.08% upside

Arcadia Biosciences (NASDAQ:RKDA) Consensus Price Target History

Price Target History for Arcadia Biosciences (NASDAQ:RKDA)

Arcadia Biosciences (NASDAQ:RKDA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/14/2018Piper Jaffray CompaniesSet Price TargetHold$20.00HighView Rating Details
6/2/2016Credit Suisse GroupReiterated RatingBuyN/AView Rating Details
(Data available from 5/22/2016 forward)

Earnings

Arcadia Biosciences (NASDAQ:RKDA) Earnings History and Estimates Chart

Earnings by Quarter for Arcadia Biosciences (NASDAQ:RKDA)

Arcadia Biosciences (NASDAQ RKDA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2018N/AView Earnings Details
5/9/2018Q1 2018($4.86)$0.21 millionViewN/AView Earnings Details
3/20/2018Q4 2017($2.00)($1.39)$1.43 millionViewN/AView Earnings Details
11/9/2017Q3 2017($1.60)($2.20)$0.59 millionViewN/AView Earnings Details
8/10/2017Q2 2017($2.20)($1.88)$0.99 millionViewN/AView Earnings Details
5/10/2017Q1 2017($1.40)($2.00)$1.02 millionViewN/AView Earnings Details
3/8/2017Q4 2016($2.00)($2.56)$0.54 millionViewListenView Earnings Details
11/10/2016Q316($1.40)($1.80)$2.10 million$1.08 millionViewListenView Earnings Details
8/9/2016Q216($1.40)($2.00)$1.90 million$0.72 millionViewListenView Earnings Details
5/10/2016Q116($1.40)($2.40)$1.60 million$0.85 millionViewListenView Earnings Details
3/8/2016Q415($1.40)($1.80)$2.40 million$1.35 millionViewListenView Earnings Details
11/5/2015Q315($1.40)($2.20)$2.40 million$1.82 millionViewN/AView Earnings Details
8/10/2015Q215($2.20)($3.80)$2.90 million$1.43 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Arcadia Biosciences (NASDAQ:RKDA) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Arcadia Biosciences (NASDAQ RKDA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 17.70%
Institutional Ownership Percentage: 15.20%
Insider Trading History for Arcadia Biosciences (NASDAQ:RKDA)

Arcadia Biosciences (NASDAQ RKDA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/23/2018Eric J ReyDirectorSell5,000$33.44$167,200.0012,335View SEC Filing  
3/23/2018Zhongjin LuVPSell1,750$32.74$57,295.002,308View SEC Filing  
3/15/2018Eric J ReyDirectorSell21,255$45.38$964,551.9028,340View SEC Filing  
11/17/2017Zhongjin LuVPSell5,950$0.23$1,368.5011,153View SEC Filing  
6/8/2017Eric J ReyDirectorBuy5,000$0.75$3,750.00146,680View SEC Filing  
8/4/2016Roger SalamehCOOSell100$2.51$251.0011,515View SEC Filing  
6/13/2016Steven F BrandweinInsiderSell8,280$2.49$20,617.20750View SEC Filing  
4/25/2016Steven F BrandweinInsiderSell1,720$2.42$4,162.409,030View SEC Filing  
4/5/2016Vic C KnaufInsiderSell2,853$2.98$8,501.9448,334View SEC Filing  
3/4/2016Vic C KnaufInsiderSell3,273$3.20$10,473.6047,434View SEC Filing  
2/3/2016Eric J. ReyCEOSell3,200$2.92$9,344.00140,180View SEC Filing  
2/1/2016Vic C. KnaufinsiderSell1,666$3.00$4,998.0047,134View SEC Filing  
12/15/2015Steven F. BrandweininsiderSell10,035$3.57$35,824.9510,000View SEC Filing  
12/2/2015Vic C. KnaufinsiderSell15,000$4.01$60,150.0047,134View SEC Filing  
11/11/2015Vic C. KnaufinsiderSell4,527$2.91$13,173.5747,134View SEC Filing  
10/9/2015Eric J. ReyCEOSell5,145$3.01$15,486.45139,630View SEC Filing  
10/8/2015Eric J. ReyCEOSell9,100$3.13$28,483.00128,993View SEC Filing  
10/5/2015Eric J. ReyCEOSell21,636$3.07$66,422.52110,160View SEC Filing  
9/30/2015Eric J. ReyCEOSell15,900$3.46$55,014.0064,160View SEC Filing  
9/25/2015Eric J. ReyCEOSell21,089$4.27$90,050.0335,803View SEC Filing  
9/14/2015Don EmlayVPSell3,521$4.95$17,428.9517,729View SEC Filing  
9/11/2015Zhongjin LuVPSell1,068$4.92$5,254.5614,760View SEC Filing  
9/10/2015Vic C. KnaufinsiderSell6,840$5.50$37,620.0031,661View SEC Filing  
9/10/2015Zhongjin LuVPSell6,672$5.48$36,562.5612,870View SEC Filing  
5/20/2015Terri C BishopMajor ShareholderBuy1,000,000$8.00$8,000,000.00View SEC Filing  
5/20/2015Uday GargDirectorBuy375,000$8.00$3,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Arcadia Biosciences (NASDAQ RKDA) News Headlines

Source:
DateHeadline
Financial Review: Arcadia Biosciences (RKDA) vs. Its CompetitorsFinancial Review: Arcadia Biosciences (RKDA) vs. Its Competitors
www.americanbankingnews.com - May 20 at 3:09 AM
Arcadia Biosciences (RKDA) versus Its Competitors Financial ReviewArcadia Biosciences (RKDA) versus Its Competitors Financial Review
www.americanbankingnews.com - May 19 at 5:27 AM
Arcadia Biosciences (RKDA) & Its Peers Head-To-Head ContrastArcadia Biosciences (RKDA) & Its Peers Head-To-Head Contrast
www.americanbankingnews.com - May 18 at 11:24 PM
Comparing Arcadia Biosciences (RKDA) & The CompetitionComparing Arcadia Biosciences (RKDA) & The Competition
www.americanbankingnews.com - May 18 at 11:24 PM
Arcadia Biosciences (RKDA) vs. The Competition Head to Head AnalysisArcadia Biosciences (RKDA) vs. The Competition Head to Head Analysis
www.americanbankingnews.com - May 18 at 7:27 PM
Arcadia Biosciences (RKDA) and Its Competitors Head-To-Head SurveyArcadia Biosciences (RKDA) and Its Competitors Head-To-Head Survey
www.americanbankingnews.com - May 18 at 10:51 AM
Arcadia Biosciences (RKDA) vs. Its Rivals Head-To-Head SurveyArcadia Biosciences (RKDA) vs. Its Rivals Head-To-Head Survey
www.americanbankingnews.com - May 17 at 3:26 PM
Comparing Arcadia Biosciences (RKDA) and The CompetitionComparing Arcadia Biosciences (RKDA) and The Competition
www.americanbankingnews.com - May 17 at 5:19 AM
Arcadia Biosciences (RKDA) versus Its Competitors Head-To-Head AnalysisArcadia Biosciences (RKDA) versus Its Competitors Head-To-Head Analysis
www.americanbankingnews.com - May 16 at 11:12 PM
Contrasting Arcadia Biosciences (RKDA) & The CompetitionContrasting Arcadia Biosciences (RKDA) & The Competition
www.americanbankingnews.com - May 16 at 9:18 PM
Head-To-Head Comparison: Evogene (EVGN) versus Arcadia Biosciences (RKDA)Head-To-Head Comparison: Evogene (EVGN) versus Arcadia Biosciences (RKDA)
www.americanbankingnews.com - May 16 at 1:27 PM
Head-To-Head Survey: Arcadia Biosciences (RKDA) & The CompetitionHead-To-Head Survey: Arcadia Biosciences (RKDA) & The Competition
www.americanbankingnews.com - May 16 at 10:58 AM
Head-To-Head Comparison: Arcadia Biosciences (RKDA) versus Its CompetitorsHead-To-Head Comparison: Arcadia Biosciences (RKDA) versus Its Competitors
www.americanbankingnews.com - May 16 at 1:09 AM
Albert D. Bolles, Ph.D. Joins Arcadia Biosciences Board Of DirectorsAlbert D. Bolles, Ph.D. Joins Arcadia Biosciences Board Of Directors
finance.yahoo.com - May 15 at 10:26 AM
Arcadia Biosciences (RKDA) vs. Its Competitors Financial ComparisonArcadia Biosciences (RKDA) vs. Its Competitors Financial Comparison
www.americanbankingnews.com - May 15 at 5:18 AM
Head-To-Head Survey: Arcadia Biosciences (RKDA) versus Its RivalsHead-To-Head Survey: Arcadia Biosciences (RKDA) versus Its Rivals
www.americanbankingnews.com - May 14 at 11:16 PM
Contrasting Arcadia Biosciences (RKDA) & Its CompetitorsContrasting Arcadia Biosciences (RKDA) & Its Competitors
www.americanbankingnews.com - May 14 at 3:19 PM
Financial Review: Arcadia Biosciences (RKDA) versus Its RivalsFinancial Review: Arcadia Biosciences (RKDA) versus Its Rivals
www.americanbankingnews.com - May 12 at 7:18 PM
Comparing Arcadia Biosciences (RKDA) & Its CompetitorsComparing Arcadia Biosciences (RKDA) & Its Competitors
www.americanbankingnews.com - May 12 at 5:11 PM
Arcadia Biosciences (RKDA) & The Competition Critical SurveyArcadia Biosciences (RKDA) & The Competition Critical Survey
www.americanbankingnews.com - May 12 at 1:39 PM
Arcadia Biosciences (RKDA) and The Competition Head-To-Head ReviewArcadia Biosciences (RKDA) and The Competition Head-To-Head Review
www.americanbankingnews.com - May 12 at 1:14 AM
SenesTech (SNES) versus Arcadia Biosciences (RKDA) Financial AnalysisSenesTech (SNES) versus Arcadia Biosciences (RKDA) Financial Analysis
www.americanbankingnews.com - May 11 at 5:33 PM
Arcadia Biosciences (RKDA) versus Its Rivals Head-To-Head ContrastArcadia Biosciences (RKDA) versus Its Rivals Head-To-Head Contrast
www.americanbankingnews.com - May 11 at 3:01 PM
Arcadia Biosciences (RKDA) and Its Competitors Critical SurveyArcadia Biosciences (RKDA) and Its Competitors Critical Survey
www.americanbankingnews.com - May 11 at 2:55 PM
Financial Survey: Arcadia Biosciences (RKDA) vs. The CompetitionFinancial Survey: Arcadia Biosciences (RKDA) vs. The Competition
www.americanbankingnews.com - May 10 at 3:59 PM
Arcadia Biosciences (RKDA) vs. Its Rivals Head to Head ComparisonArcadia Biosciences (RKDA) vs. Its Rivals Head to Head Comparison
www.americanbankingnews.com - May 10 at 11:49 AM
Arcadia Biosciences (RKDA) vs. Its Competitors Head to Head AnalysisArcadia Biosciences (RKDA) vs. Its Competitors Head to Head Analysis
www.americanbankingnews.com - May 10 at 10:46 AM
Edited Transcript of RKDA earnings conference call or presentation 9-May-18 8:30pm GMTEdited Transcript of RKDA earnings conference call or presentation 9-May-18 8:30pm GMT
finance.yahoo.com - May 10 at 10:02 AM
Arcadia Biosciences: 1Q Earnings SnapshotArcadia Biosciences: 1Q Earnings Snapshot
finance.yahoo.com - May 10 at 10:02 AM
Arcadia Biosciences (RKDA) & Its Competitors Financial AnalysisArcadia Biosciences (RKDA) & Its Competitors Financial Analysis
www.americanbankingnews.com - May 10 at 5:14 AM
Financial Review: Arcadia Biosciences (RKDA) and The CompetitionFinancial Review: Arcadia Biosciences (RKDA) and The Competition
www.americanbankingnews.com - May 9 at 5:29 PM
Arcadia Biosciences (RKDA) & Its Competitors Critical ComparisonArcadia Biosciences (RKDA) & Its Competitors Critical Comparison
www.americanbankingnews.com - May 9 at 5:29 PM
Is Arcadia Biosciences Inc’s (NASDAQ:RKDA) CEO Incentives Align With Yours?Is Arcadia Biosciences Inc’s (NASDAQ:RKDA) CEO Incentives Align With Yours?
finance.yahoo.com - May 9 at 4:13 PM
Arcadia Biosciences Announces First-Quarter 2018 Financial Results and Business HighlightsArcadia Biosciences Announces First-Quarter 2018 Financial Results and Business Highlights
finance.yahoo.com - May 9 at 4:13 PM
Critical Comparison: Arcadia Biosciences (RKDA) versus Its CompetitorsCritical Comparison: Arcadia Biosciences (RKDA) versus Its Competitors
www.americanbankingnews.com - May 9 at 2:33 PM
Financial Review: Arcadia Biosciences (RKDA) and Its CompetitorsFinancial Review: Arcadia Biosciences (RKDA) and Its Competitors
www.americanbankingnews.com - May 9 at 11:57 AM
Reviewing Arcadia Biosciences (RKDA) and Its RivalsReviewing Arcadia Biosciences (RKDA) and Its Rivals
www.americanbankingnews.com - May 9 at 11:57 AM
Arcadia Biosciences (RKDA) versus The Competition Financial ComparisonArcadia Biosciences (RKDA) versus The Competition Financial Comparison
www.americanbankingnews.com - May 8 at 11:18 PM
Critical Survey: Arcadia Biosciences (RKDA) versus Its PeersCritical Survey: Arcadia Biosciences (RKDA) versus Its Peers
www.americanbankingnews.com - May 8 at 9:09 PM
Reviewing Arcadia Biosciences (RKDA) & Its CompetitorsReviewing Arcadia Biosciences (RKDA) & Its Competitors
www.americanbankingnews.com - May 8 at 9:09 PM
Contrasting Arcadia Biosciences (RKDA) and The CompetitionContrasting Arcadia Biosciences (RKDA) and The Competition
www.americanbankingnews.com - May 8 at 5:19 PM
Arcadias engineered rice boost yields as much as 50%; shares up 26% premarketArcadia's engineered rice boost yields as much as 50%; shares up 26% premarket
seekingalpha.com - May 8 at 9:43 AM
Arcadia Biosciences’ Traits Increase Rice Yields By Double DigitsArcadia Biosciences’ Traits Increase Rice Yields By Double Digits
finance.yahoo.com - May 8 at 9:43 AM
Arcadia Biosciences stock rockets after trial results showed input traits boosted rice crop yieldsArcadia Biosciences' stock rockets after trial results showed 'input traits' boosted rice crop yields
finance.yahoo.com - May 8 at 9:43 AM
Head-To-Head Comparison: Arcadia Biosciences (RKDA) vs. Its PeersHead-To-Head Comparison: Arcadia Biosciences (RKDA) vs. Its Peers
www.americanbankingnews.com - May 7 at 1:08 AM
Head to Head Contrast: Arcadia Biosciences (RKDA) & Its CompetitorsHead to Head Contrast: Arcadia Biosciences (RKDA) & Its Competitors
www.americanbankingnews.com - May 6 at 10:12 AM
Head-To-Head Analysis: Arcadia Biosciences (RKDA) & The CompetitionHead-To-Head Analysis: Arcadia Biosciences (RKDA) & The Competition
www.americanbankingnews.com - May 5 at 9:58 AM
Financial Comparison: Arcadia Biosciences (RKDA) versus Its CompetitorsFinancial Comparison: Arcadia Biosciences (RKDA) versus Its Competitors
www.americanbankingnews.com - May 5 at 9:44 AM
Contrasting Arcadia Biosciences (RKDA) and Its CompetitorsContrasting Arcadia Biosciences (RKDA) and Its Competitors
www.americanbankingnews.com - May 5 at 9:33 AM
Analyzing Arcadia Biosciences (RKDA) & Its RivalsAnalyzing Arcadia Biosciences (RKDA) & Its Rivals
www.americanbankingnews.com - May 5 at 3:13 AM

SEC Filings

Arcadia Biosciences (NASDAQ:RKDA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Arcadia Biosciences (NASDAQ:RKDA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Arcadia Biosciences (NASDAQ RKDA) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.